Despite living in a famously sunny country, we've been getting reports of widespread vitamin D deficiency for some time now. The solution to this problem is simply the judicious use of a plentiful, if somewhat maligned, natural ...
Jul 4, 2013
0
0
U.S. and Italian researchers have determined that brain reserve, as well as cognitive reserve, independently protects against cognitive decline in multiple sclerosis (MS). Their article, "Brain reserve and cognitive reserve ...
Jun 25, 2013
0
0
(Medical Xpress)—A UC San Francisco-led research team has identified the likely genetic mechanism that causes some patients with multiple sclerosis (MS) to progress more quickly than others to a debilitating stage of the ...
Jun 25, 2013
0
0
Myelin, the fatty coating that protects neurons in the brain and spinal cord, is destroyed in diseases such as multiple sclerosis. Researchers have been striving to determine whether oligodendrocytes, the cells that produce ...
Jun 24, 2013
0
2
There is no cure for tremor. That means for patients who suffer from the ailment – characterized by involuntary muscle contractions and shaking – ordinary tasks become increasingly difficult. Buttoning shirts, cooking ...
Jun 21, 2013
0
0
Shareholders of Irish drugmaker Elan Corp. PLC have potentially ended a takeover bid from Royalty Pharma by voting in favor of an Elan share buyback plan.
Jun 17, 2013
0
0
(Medical Xpress)—A medical test previously developed to measure a toxin found in tobacco smokers has been adapted to measure the same toxin in people suffering from spinal cord injuries and multiple sclerosis, offering ...
Jun 13, 2013
0
0
Irish biotechnology company Elan rejected on Monday the latest takeover bid from US group Royalty Pharma worth about $7.9 billion (6.0 billion euros).
Jun 10, 2013
0
0
Shares of Elan Corp. PLC jumped Friday after Royalty Pharma once again raised its offer to buy the Irish drugmaker in an increasingly bitter takeover fight.
Jun 7, 2013
0
0
A study by Hans-Peter Hartung, M.D., of Heinrich-Heine-Universität, Düsseldoft, Germany, and colleagues examines the association between IL-17F and treatment response to interferon beta-1b among patients with relapsing-remitting ...
Jun 3, 2013
0
0
